ArticleCureus2026
Solitary Fibrous Tumours in the Central Nervous System and Their Clinical Mimickers: A Case Series.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Solitary fibrous tumours (SFT) of the central nervous system (CNS) are rare mesenchymal neoplasms. Challenges arise at the time of diagnosis due to their overlapping clinical, radiological, and histopathological features with other spindle cell tumours. We present four cases of SFTs arising at different anatomical locations across the CNS. The patients presented with varied clinical symptoms and radiological findings, leading to an initial diagnosis of other mimickers, such as fibrous meningioma, neurofibroma, and other spindle cell tumours. Histopathological examination revealed tumours composed of spindle cells and branching, staghorn-like vasculature. Immunohistochemical evaluation with STAT6 was performed in all the cases to distinguish SFT from its histological mimickers. It demonstrated diffuse nuclear staining of tumour cells in all four cases. Based on the histology, mitotic activity, and necrosis, the tumours were classified as CNS WHO Grades 1, 2, and 3. These cases highlight the varied clinical and radiological presentations of CNS SFTs. They also emphasise the importance of careful histopathological assessment with appropriate immunohistochemical workup for accurate diagnosis. Awareness of this entity and its mimickers is essential to avoid misdiagnosis and ensure appropriate patient management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.